問卷

TPIDB > Principal Investigator

Principal Investigator


Linkou Chang Gung Medical Foundation (在職)

Division of Dermatology

更新時間:2023-09-19

紀敏慧
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

4Cases

2020-10-09 - 2020-12-10

Phase III

Completed
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
7Sites

Terminated7Sites

2026-07-01 - 2027-12-31

Phase II

Not yet recruiting
A phase II, double-blind trial was conducted to determine the safety, tolerability, and efficacy of AR100DP1 in subjects with mild to moderate atopic dermatitis.
  • Condition/Disease

    Atopic dermatitis

  • Test Drug

    AR100DP1

Participate Sites
2Sites

Not yet recruiting1Sites

2023-07-01 - 2029-08-10

Phase III

Active
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
6Sites

Recruiting6Sites

2018-08-01 - 2023-07-31

Others

  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites